The short version of synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-07 and is reviewed periodically as new material appears.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
cytoplasm All of the material contained within a cell excluding (in eukaryotes) the nucleus; i.e. that part of the protoplasm which is enclosed by the plasma membrane but separated from the nucleoplasm by the nuclear envelope, consisting of the fluid cytosol and the totality of its contents, including all of the cell's internal compartments, organelles, and substructures such as mitochondria, lysosomes, the endoplasmic reticulum, vesicles and inclusions, and a network of filamentous microtubules known as the cytoskeleton. Some definitions of cytoplasm exclude certain organelles such as vacuoles and plastids. Composed of about 80 percent water, the numerous small molecules and macromolecular complexes dissolved or suspended within the cytoplasm give it characteristic viscoelastic and thixotropic properties, allowing it to behave variously as a gel or a liquid solution. Though continuous throughout the intracellular space, the cytoplasm can often be resolved into distinct phases of different density and composition, such as an endoplasm and ectoplasm. Most of the metabolic and biosynthetic activities of the cell take place in the cytoplasm, including protein synthesis by ribosomes. Despite their physical separation, the cytoplasm and the nucleus are mutually dependent upon each other, such that an isolated nucleus without cytoplasm is as incapable of surviving for long periods as is the cytoplasm without a nucleus.
Sanders' proposed legislation include worker-owned business, the Workplace Democracy Act, employee ownership as alternative to corporations and a package to encourage employee-owned companies. Sanders associates Franklin D. Roosevelt's New Deal and Lyndon B. Johnson's Great Society as part of the democratic socialist tradition and claimed the New Deal's legacy to "take up the unfinished business of the New Deal and carry it to completion." While opponents of Sanders have used the democratic socialist label to accuse him of being too left-leaning for American politics, the theoretical and practical applications of it are based on the precept of shifting responsibility away from the national level to local decision-makers, a fundamental principle shared by the system of federalism in the United States. A democratic socialist perspective on government investment in infrastructure would support more projects with smaller-sized budgets on a local level instead of a few highly expensive ones. This view aligns with the Republican Party's fundamental identity, philosophy and agenda of local people exerting control over their own affairs. In a 2018 poll conducted by Gallup, a majority of people under the age of 30 in the United States stated that they approve of socialism. 57% of Democratic-leaning voters viewed socialism positively and 47% saw capitalism positively while 71% of Republican-leaning voters who were polled saw capitalism under a positive light and 16% viewed socialism in a positive light.
=== Basic sciences === Anatomy is the study of the physical structure of organisms. In contrast to macroscopic or gross anatomy, cytology and histology are concerned with microscopic structures. Biochemistry is the study of the chemistry taking place in living organisms, especially the structure and function of their chemical components. Biomechanics is the study of the structure and function of biological systems by means of the methods of Mechanics. Biophysics is an interdisciplinary science that uses the methods of physics and physical chemistry to study biological systems. Biostatistics is the application of statistics to biological fields in the broadest sense. A knowledge of biostatistics is essential in the planning, evaluation, and interpretation of medical research. It is also fundamental to epidemiology and evidence-based medicine. Cytology is the microscopic study of individual cells.
When FUCA matured, its genetic code was then completely established. It has been proposed that FUCA was composed by a population of open-systems, exchanging components and information with the environment, and a population of self-replicating ribonucleoproteins. The progenote era began when these interaction systems arrived. These systems reached maturity when self-organization processes resulted in the emergence of a genetic code. This genetic code was, for the first time, able to organize an ordered interaction between nucleic acids and proteins through the formation of a biological language. This caused pre-cellular open systems to start to accumulate information and self-organizing, producing the first genomes by the assembling biochemical pathways. The pathways probably appeared in different progenote populations that independently evolved.
Cardiac muscle cells are the contracting cells that allow the heart to pump. Each cardiomyocyte needs to contract in coordination with its neighboring cells - known as a functional syncytium - working to efficiently pump blood from the heart, and if this coordination breaks down then – despite individual cells contracting – the heart may not pump at all, such as may occur during abnormal heart rhythms such as ventricular fibrillation. Viewed through a microscope, cardiac muscle cells are roughly rectangular, measuring 100–150μm by 30–40μm. Individual cardiac muscle cells are joined at their ends by intercalated discs to form long fibers. Each cell contains myofibrils, specialized protein contractile fibers of actin and myosin that slide past each other. These are organized into sarcomeres, the fundamental contractile units of muscle cells. The regular organization of myofibrils into sarcomeres gives cardiac muscle cells a striped or striated appearance when looked at through a microscope, similar to skeletal muscle. These striations are caused by lighter I bands composed mainly of actin, and darker A bands composed mainly of myosin. Cardiomyocytes contain T-tubules, pouches of cell membrane that run from the cell surface to the cell's interior which help to improve the efficiency of contraction. The majority of these cells contain only one nucleus (some may have two central nuclei), unlike skeletal muscle cells which contain many nuclei.
Sources: en.wikipedia.org
=== Chemical structure === β-Hydroxy β-methylbutyric acid is a member of the carboxylic acid family of organic compounds. It is a structural analog of butyric acid with a hydroxyl functional group and a methyl substituent located on its beta carbon. By extension, other structural analogs include β-hydroxybutyric acid and β-methylbutyric acid.
From this colony later originated the founding of Paestum (in Lucania), Lao (at the mouth of the river of the same name) and Scidros (between Cetraro and Belvedere Marittimo). Ionian colonies were Clampetia (in the area between Amantea and San Lucido), Temesa (between Amantea and Nocera Terinese), Terina (in the plain of Sant'Eufemia), Krimisa (Cirò Marina), Petelia (Strongoli). In 743 BCE Achaean settlers instead founded Kroton (current Crotone), on the point now known as Capo Colonna. Crotonians and Sybarites later became rivals. Crotonians founded the colonies of Caulonia (near today's Monasterace Marina) and Scillezio (Squillace). Around 700 BCE Crotonian colonists founded Bristacia, current Umbriatico. Around 680 BCE colonists from the Greek Locris founded Epizephyrian Locris, near present-day Locri. Locrians founded Hipponion (Vibo Valentia) and Medma (Rosarno). The Bruttians, similar to the neighboring Lucanians, declared themselves independent of their “cousins” from beyond the Pollino around the 4th century BCE, forming a confederate state. The capital of the federates was Consentia, present-day Cosenza. It was one of the main cities along with Pandosia, a city whose traces have been lost; some historical references locate it among the municipalities of Castrolibero, Marano Principato, and Marano Marchesato, while other recent archaeological discoveries locate the city near the present city of Acri, Aufugum (Montalto Uffugo), Argentanum (San Marco Argentano), Bergae, Besidiae (Bisignano), and Lymphaeum (Luzzi).
(2026) determine the diet and habitats of Pleistocene Notiomastodon platensis, Toxodon platensis and cf. Eremotherium from the Teles Pires basin in Brazilian Amazon on the basis of tooth wear and carbon and oxygen stable isotope data from their remains, interpreting T. platensis and cf. Eremotherium as browsers from woodland habitats, and interpreting different individuals of N. platensis as browsers from woodlands and mixed feeders from savanna-like landscapes. Brito, Leal & Dantas (2026) report the discovery of a new assemblage of Pleistocene mammals from fossiliferous tank deposits in the municipalities of Mirante and Anagé (Bahia, Brazil), and interpret carbon and oxygen isotopic composition of the studied bones as consistent with overall generalist herbivorous diets of the studied mammals. Oliveira et al. (2026) study the composition of the Late Pleistocene mammalian assemblage from the Toca Fria cave (Brazil), and interpret the studied assemblage as including mammals from two habitas: a low-density forest and an open savanna. Carrasco et al. (2026) report evidence of losses of functional diversity of terrestrial mammalian assemblages from Brazilian Pampa resulting from late Quaternary extinctions, and find that only some of the introduced mammals might be ecological substitutes for extinct megafauna. Neves et al.
== Literature == Emanuel Gil-Av, Present status of enantiomeric analysis by gas chromatography, J. Mol. Evol. 6 (1975) 131–144. Nelu Grinberg: Emanuel Gil-Av (1916–1996): A man with a legacy, In: Chirality, 1998;10(5):372. Volker Schurig: In Memoriam – Emanuel Gil-Av. In: Journal of High Resolution Chromatography 19 (1996) 462. Volker Schurig: On the Centenary of Emanuel Gil-Av, Former Professor of the Weizmann Institute of Science and Pioneer of Enantioselective Chromatography, Isr. J. Chem. 56 (2016) 890–906.
"What we know about the US-Israeli attack on Iran and Tehran's retaliation". CNN. 28 February 2026. Retrieved 28 February 2026. U.S. and Israeli Strikes on Iran, C-SPAN Tracking of traffic in the Strait of Hormuz
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.